Age at inclusion, years |
51±15.5 |
54.31±14 |
49.34±15.84 |
0.34 |
|
Male sex, n (%) |
33 (73.3%) |
10 (76.9%) |
23 (71.9%) |
0.72 |
|
Family history of HCM, n (%) |
7 (15.56%) |
4 (30.77%) |
3 (9.4%) |
0.47 |
|
Family history of SCD, n (%) |
14 (31.1%) |
3 (23.1%) |
11 (34.4%) |
0.45 |
|
ICD, n (%) |
7 (15.56%) |
3 (23.1%) |
4 (12.5 %) |
0.56 |
|
Atrial fibrillation, n (%) |
22 (48.9%) |
7 (53.8%) |
15 (46.9%) |
0.67 |
|
Maron classification, n (%) |
|
|
|
0.32 |
1 |
7 (15.56%) |
1 (7.7%) |
6 (18.8%) |
|
2 |
5 (11.1%) |
2 (15.4%) |
3 (9.4%) |
|
3 |
32 (71.1%) |
9 (69.2%)) |
23 (71.9%) |
|
4 |
1 (2.2%) |
1 (7.7%) |
0 |
|
|
Presence of LVOTO, n (%) |
20 (44.44%) |
7 (53.9%) |
13 (40.6%) |
0.53 |
|
LV maximal wall thickness, mm |
20.8±5.2 |
20.61±6.58 |
20.69±4.58 |
0.32 |
|
LV mass, g |
279.91±90.72 |
297±90.62 |
272.04±91.6 |
0.51 |
|
LVEDD, mm |
41.21±7.87 |
42.72±7.49 |
40.59±8.07 |
0.44 |
|
LVESD, mm |
25.31±9.77 |
24.18±5.27 |
25.83±111.32 |
0.98 |
|
LVEDV, ml |
111.42±39.6 |
125.55±45.8 |
106.12±36.68 |
0.41 |
|
LVESV, ml |
55.55±30.13 |
55.69±32.56 |
56.74±29.63 |
0.98 |
|
LVEF, % |
57.09±7.64 |
56.35±5.86 |
57.39±7.12 |
0.66 |
|
LAD, mm |
40.92±6.86 |
41.09±8.69 |
40.85±6.13 |
0.88 |
|
LAV, ml |
90.32±41.75 |
87.5±41.06 |
91.42±42.75 |
0.68 |